Novartis AG (NYSE:NVS)

77.60
Delayed Data
As of Apr 23
 -0.28 / -0.36%
Today’s Change
74.06
Today|||52-Week Range
94.19
-7.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line1.7B2.0B2.1B2.0B
 
 
 
 
 
Depreciation1.8B1.4B1.5B584.8M
 
 
 
 
 
Total Other Cash Flow13.1M67.6M-142.3M1.2B
 
 
 
 
 
Funds From Operations3.5B3.4B3.5B3.0B
 
 
 
 
 
Funds From/For Other Operating Expenses1.4B-180.8M-167.5M-434.7M
 
 
 
 
 
Net Cash Flow - Operating Activities2.1B3.6B3.6B3.4B
 
 
 
 
 
 
InvestingIncrease In Investments-15.1M------
 
 
Decrease In Investments-----18.2M878.3M
 
 
 
Capital Expenditures-346.5M-335.8M-385.6M-636.5M
 
 
 
 
 
Fixed Asset Disposal355.5M258.1M-272.5M-248.7M
 
 
 
 
 
Net Assets From Acquisitions -663.7M2.7M-106.0M-20.8M
 
 
 
 
 
Other Investing - Uses-47.3M-40.5M-386.6M291.5M
 
 
 
 
 
Other Investing - Sources------99.1M
 
 
Net Cash Flow Investing-1.1B-342.4M-691.4M-1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings7.3B-1.2B-581.1M-532.3M
 
 
 
 
 
Long Term Debt Reduction----------
Net Proceeds Stock Sale0.000.000.00253.2M
 
 
Common Preferred Redeemed-1.1B-1.9B-1.4B-1.1B
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-6.5B-13.4M-244.5K28.4M
 
 
 
 
 
Other Sources - Financing----37.3M-40.4M
 
 
 
Other Uses - Financing69.5M------
 
 
Net Cash Flow - Financing-390.8M-3.0B-2.0B-2.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash9.1M51.5M-10.1M33.9M
 
 
 
 
 
 
Net Change In Cash560.0M236.3M973.0M8.4M